CAS 1073059-33-2
:Sortieren nach
Reinheit (%)
0
100
|
0
|
50
|
90
|
95
|
100
2 Produkte.
Samalizumab
CAS:<p>Samalizumab (anti-CD200 mAb) is an immune checkpoint inhibitor under investigation for treating myeloma and B-cell CLL.</p>Reinheit:95%Farbe und Form:Liquid
